No Increased Risk of Hepatitis B Virus Infection in Patients with Celiac Disease: A Population-Based Study
In a population-based Swedish cohort, there was no increased risk of developing HBV in individuals with CeD. This finding does not support current practices of testing and revaccination for HBV. Additional studies should be completed in areas with higher endemic rates of HBV. Slightly higher rates of prior HBV infection in CeD may be secondary to increased testing in those seeking medical care for another disease process.
Authors
- Peter H.R. Green
- Soo Aleman (ORCID: https://orcid.org/0000-0003-0461-4870)
- Hannes Hagström (ORCID: https://orcid.org/0000-0002-8474-1759)
- Jonas Filip Ludvigsson (ORCID: https://orcid.org/0000-0003-1024-5602)
- Ann‐Sofi Duberg (ORCID: https://orcid.org/0000-0001-7248-0910)
- Benjamin Lebwohl
- Jacqueline Jossen
- Rajani Sharma (ORCID: https://orcid.org/0000-0001-6439-4537)
- Jonas Söderling (ORCID: https://orcid.org/0000-0001-9006-2835)
Institutions
- Karolinska University Hospital (SE)
- Örebro University (SE)
- Columbia University Irving Medical Center (US)
- Karolinska Institutet (SE)
- Örebro University Hospital (SE)
- Columbia University (US)
Publication Details
- Journal
- Digestive Diseases and Sciences
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1007/s10620-025-08878-3
- Citations
- 1
- Primary Topic
- Celiac Disease Research and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.81
Funders
- Karolinska Institutet